Literature DB >> 22866129

Extragastrointestinal stromal tumor originating from the vulva.

Takeshi Fukuda1, Toshiyuki Sumi, Yusuke Nakano, Masanari Morishita, Hiroyuki Nobeyama, Hiroyuki Yoshida, Yoshinari Matsumoto, Tomoyo Yasui, Ken-Ichi Honda, Osamu Ishiko.   

Abstract

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. They have gain-of-function mutations of the c-kit receptor tyrosine kinase gene and have been suggested to originate from the interstitial cells of Cajal. A small percentage of GISTs form extragastrointestinal masses. We report a rare case of a GIST originating from the vulva. A 55-year-old woman presented with a vulvar tumor. The tumor was initially diagnosed as a leiomyosarcoma following the first resection. Following a second recurrence the patient was administered chemotherapy. A third recurrence occurred and the patient underwent a third resection. Histology revealed that a bundle of fibrous tumor cells had invaded the connected tissue and muscular coat, and some spindle-shaped and blunt-ended nuclei were detected. Furthermore, immunohistochemical evaluation revealed that the tumor cells exhibited strong and diffuse staining for c-kit and CD34. The recurrent tumor was diagnosed as a GIST and a reevaluation of the original specimens also revealed a GIST. The patient was treated with imatinib, and is currently healthy with no evidence of recurrence at 20 months after the last surgery.

Entities:  

Year:  2011        PMID: 22866129      PMCID: PMC3408102          DOI: 10.3892/ol.2011.343

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  11 in total

1.  Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal.

Authors:  L G Kindblom; H E Remotti; F Aldenborg; J M Meis-Kindblom
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

Review 2.  Gastrointestinal stromal tumors: pathology and prognosis at different sites.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  Semin Diagn Pathol       Date:  2006-05       Impact factor: 3.464

Review 3.  Practical management of patients with chronic myeloid leukemia receiving imatinib.

Authors:  Michael W N Deininger; Stephen G O'Brien; John M Ford; Brian J Druker
Journal:  J Clin Oncol       Date:  2003-03-13       Impact factor: 44.544

4.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.

Authors:  S Hirota; K Isozaki; Y Moriyama; K Hashimoto; T Nishida; S Ishiguro; K Kawano; M Hanada; A Kurata; M Takeda; G Muhammad Tunio; Y Matsuzawa; Y Kanakura; Y Shinomura; Y Kitamura
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

5.  Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases.

Authors:  M Miettinen; J M Monihan; M Sarlomo-Rikala; A J Kovatich; N J Carr; T S Emory; L H Sobin
Journal:  Am J Surg Pathol       Date:  1999-09       Impact factor: 6.394

6.  Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.

Authors:  Markku Miettinen; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2009-09       Impact factor: 6.394

Review 7.  Diagnosis of gastrointestinal stromal tumors: A consensus approach.

Authors:  Christopher D M Fletcher; Jules J Berman; Christopher Corless; Fred Gorstein; Jerzy Lasota; B Jack Longley; Markku Miettinen; Timothy J O'Leary; Helen Remotti; Brian P Rubin; Barry Shmookler; Leslie H Sobin; Sharon W Weiss
Journal:  Hum Pathol       Date:  2002-05       Impact factor: 3.466

8.  Interstitial cells of Cajal generate a rhythmic pacemaker current.

Authors:  L Thomsen; T L Robinson; J C Lee; L A Farraway; M J Hughes; D W Andrews; J D Huizinga
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440

9.  Management of Skin Toxicity Related to the Use of Imatinib Mesylate (STI571, Glivectrade mark) for Advanced Stage Gastrointestinal Stromal Tumours.

Authors:  Lucy C Scott; Jeff D White; Robin Reid; Fiona Cowie
Journal:  Sarcoma       Date:  2005

10.  Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST).

Authors:  B Nilsson; K Sjölund; L-G Kindblom; J M Meis-Kindblom; P Bümming; O Nilsson; J Andersson; H Ahlman
Journal:  Br J Cancer       Date:  2007-05-29       Impact factor: 7.640

View more
  2 in total

1.  Ileal Gastrointestinal Stromal Tumor as a Rare Cause of Gastrointestinal Bleed: A Case Report and Brief Review of the Literature.

Authors:  Adnan S Khan
Journal:  Cureus       Date:  2022-03-04

2.  Synchronous leiomyosarcoma and fibroma in a single ovary: A case report and review of the literature.

Authors:  Meng He; Yan-Jie Deng; Dan-Yi Zhao; Yang Zhang; Tao Wu
Journal:  Oncol Lett       Date:  2016-02-17       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.